Hangzhou Jiuyuan Genetic Biopharmaceutical Co (HKSE:02566) Market Cap: HK$1,300 Mil (As of Aug. 16, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02566 Hangzhou Jiuyuan Genetic Biopharmaceutical Co Ltd HKSE:02566
20 GF Score
Price HK$5.41
! 1 Warning Sign
View Full Analysis

What is Hangzhou Jiuyuan Genetic Biopharmaceutical Co Market Cap?

Hangzhou Jiuyuan Genetic Biopharmaceutical Co HKSE:02566 +3.05% 20 Market Cap is HK$1,300 Mil as of Aug. 16, 2026. GuruFocus rates HKSE:02566 with a GF Score™ of 20/100. The stock has 1 warning sign investors should review. Among 1,423 Biotechnology companies, Hangzhou Jiuyuan Genetic Biopharmaceutical Co ranks better than 54.39% on this metric.

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Hangzhou Jiuyuan Genetic Biopharmaceutical Co's share price for the quarter that ended in Dec. 2025 was HK$7.56. Hangzhou Jiuyuan Genetic Biopharmaceutical Co's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 245 Mil. Therefore, Hangzhou Jiuyuan Genetic Biopharmaceutical Co's market cap for the quarter that ended in Dec. 2025 was HK$1,855 Mil.

Hangzhou Jiuyuan Genetic Biopharmaceutical Co's quarterly market cap increased from Dec. 2024 (HK$1,620 Mil) to Jun. 2025 (HK$1,926 Mil) but then declined from Jun. 2025 (HK$1,926 Mil) to Dec. 2025 (HK$1,855 Mil).

Hangzhou Jiuyuan Genetic Biopharmaceutical Co's annual market cap increased from Dec. 2023 (HK$0 Mil) to Dec. 2024 (HK$1,620 Mil) and increased from Dec. 2024 (HK$1,620 Mil) to Dec. 2025 (HK$1,855 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Hangzhou Jiuyuan Genetic Biopharmaceutical Co's Enterprise Value for Today is HK$657 Mil.


Hangzhou Jiuyuan Genetic Biopharmaceutical Co  (HKSE:02566) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Hangzhou Jiuyuan Genetic Biopharmaceutical Co Market Cap Related Terms


Hangzhou Jiuyuan Genetic Biopharmaceutical Co Market Cap Historical Data

* Premium members only.

The historical data trend for Hangzhou Jiuyuan Genetic Biopharmaceutical Co's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hangzhou Jiuyuan Genetic Biopharmaceutical Co Market Cap Chart

Hangzhou Jiuyuan Genetic Biopharmaceutical Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Market Cap
0.00 0.00 0.00 1,619.63 1,855.22

Hangzhou Jiuyuan Genetic Biopharmaceutical Co Semi-Annual Data
Dec21 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Market Cap Get a 7-Day Free Trial 0.00 0.00 1,619.63 1,926.38 1,855.22

HKSE:02566 vs VRTX, REGN, RVMD: Market Cap Comparison

For the Biotechnology subindustry, Hangzhou Jiuyuan Genetic Biopharmaceutical Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hangzhou Jiuyuan Genetic Biopharmaceutical Co Market Cap vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hangzhou Jiuyuan Genetic Biopharmaceutical Co's Market Cap distribution charts can be found below:

* The bar in red indicates where Hangzhou Jiuyuan Genetic Biopharmaceutical Co's Market Cap falls into.


HKSE:02566
20GF Score
Hangzhou Jiuyuan Genetic Biopharmaceutical Co Ltd HKSE:02566
Market Cap is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hangzhou Jiuyuan Genetic Biopharmaceutical Co Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Hangzhou Jiuyuan Genetic Biopharmaceutical Co's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as

Market Cap (A: Dec. 2025 )=Share Price (A: Dec. 2025 )*Shares Outstanding (EOP) (A: Dec. 2025 )
=HK$7.56*245.399
=HK$1,855

Hangzhou Jiuyuan Genetic Biopharmaceutical Co's Market Cap for the quarter that ended in Dec. 2025 is calculated as

Market Cap (Q: Dec. 2025 )=Share Price (Q: Dec. 2025 )*Shares Outstanding (EOP) (Q: Dec. 2025 )
=HK$7.56*245.399
=HK$1,855

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Market Cap →
What does a Market Cap of HK$1,300 Mil mean?
Hangzhou Jiuyuan Genetic Biopharmaceutical Co (HKSE:02566) has a Market Cap of HK$1,300 Mil as of Aug. 16, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Hangzhou Jiuyuan Genetic Biopharmaceutical Co and its competitors. According to the industry distribution chart, Hangzhou Jiuyuan Genetic Biopharmaceutical Co ranks #649 out of 1423 companies in the Biotechnology industry, placing it in the top 45.6%.
Is Hangzhou Jiuyuan Genetic Biopharmaceutical Co's Market Cap too high?
Hangzhou Jiuyuan Genetic Biopharmaceutical Co's current Market Cap is HK$1,300 Mil. Based on the distribution chart, Hangzhou Jiuyuan Genetic Biopharmaceutical Co ranks #649 out of 1423 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Hangzhou Jiuyuan Genetic Biopharmaceutical Co has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Hangzhou Jiuyuan Genetic Biopharmaceutical Co's Market Cap compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Hangzhou Jiuyuan Genetic Biopharmaceutical Co ranks #649 out of 1423 companies for Market Cap. This puts Hangzhou Jiuyuan Genetic Biopharmaceutical Co in the upper half of its industry. The industry median Market Cap is 118.89. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 118.89, based on 1,423 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Hangzhou Jiuyuan Genetic Biopharmaceutical Co and its competitors. For the Biotechnology industry, the median Market Cap is 118.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hangzhou Jiuyuan Genetic Biopharmaceutical Co's current Market Cap is HK$1,300 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hangzhou Jiuyuan Genetic Biopharmaceutical Co stock overvalued right now?
Hangzhou Jiuyuan Genetic Biopharmaceutical Co (HKSE:02566) has a current Market Cap of HK$1,300 Mil. The current Market Cap is HK$1,300 Mil. Hangzhou Jiuyuan Genetic Biopharmaceutical Co's overall GF Score™ is 20/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Hangzhou Jiuyuan Genetic Biopharmaceutical Co (HKSE:02566), the current Market Cap is HK$1,300 Mil as of Aug. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Hangzhou Jiuyuan Genetic Biopharmaceutical Co Business Description

Address No. 23, Eighth Street, Baiyang Street, Qiantang District, Zhejiang Province, Hangzhou, CHN
Hangzhou Jiuyuan Genetic Biopharmaceutical Co Ltd is a biopharmaceutical company in China. It is engaged in the research & development, manufacturing, and commercialization of biopharmaceutical products and medical devices. The company focuses on four large and fast-growing therapeutic areas: orthopedics, metabolic diseases, oncology, and hematology. Centered around these therapeutic areas, it has built a diversified product portfolio comprising several marketed products, such as Jilifen, Jijufen, Jiouting, Yinuojia, Guyoudao, etc., and has several product candidates under development, such as JY54, JY23, JY47, JY56, JY29-2, etc., targeting various indications. Geographically, the company generates maximum revenue from the Chinese Mainland, and the rest from other countries.
20GF Score

Get the complete analysis for HKSE:02566

Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$5.41
Price